跳至主要内容
临床试验/ACTRN12618001780246
ACTRN12618001780246已完成未知

Clinical assessment of Gallus noninvasive ventilation (NIV) mask on patients in intensive care prescribed NIV.

Fisher and Paykel Healthcare0 个研究点目标入组 67 人开始时间: 2018年10月30日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
67

研究概览

简要总结

The study demonstrated that the medical device was effective at delivering NIV therapy. Compared to the usual mask the study mask was found to be the same or better than the usual care mask in over 80% of cases.

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • All patients admitted to the Critical Care Department of Waikato Hospital that require NIV will be screened for eligibility for the study. Study participants must be adult (18 years or older and weigh more than 30kg) and require NIV in the hospital setting.

排除标准

  • Patients that fall outside of the recommended sizing range for the Gallus mask will be excluded.
  • Palliative care patients near the end of life may be omitted from the study if it is considered to be inappropriate to include them.
  • Patients can be excluded at the caregiver's discretion, for example, patients with psychological issues or agitated patients.

研究者

发起方
Fisher and Paykel Healthcare

相似试验